Literature DB >> 1667477

Formation of lentivirus particles by mammalian cells infected with recombinant fowlpox virus.

S Jenkins1, L Gritz, C H Fedor, E M O'Neill, L K Cohen, D L Panicali.   

Abstract

Recombinant fowlpox viruses (FPV) containing the env or gag-pol genes of simian immunodeficiency virus from macaques (SIVmac) were constructed. The env, gag, and pol-encoded polypeptides were efficiently expressed and processed in avian cells productively infected with FPV as well as in mammalian cells, in which FPV infection is abortive. In addition, the recombinant FPV expressing the gag-pol genes directed the formation of defective, lentivirus-like particles which were released into the culture medium of infected cells. Coinfection of cells with the env and gag-pol recombinant viruses resulted in the generation of particles containing SIVmac envelope glycoprotein. The applications of this system to vaccine development are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667477     DOI: 10.1089/aid.1991.7.991

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  16 in total

1.  Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

Authors:  S Gnjatic; Y Nagata; E Jager; E Stockert; S Shankara; B L Roberts; G P Mazzara; S Y Lee; P R Dunbar; B Dupont; V Cerundolo; G Ritter; Y T Chen; A Knuth; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.

Authors:  Shawn S Jackson; Petr Ilyinskii; Valérie Philippon; Linda Gritz; Alicia Gómez Yafal; Kimberly Zinnack; Kristin R Beaudry; Kelledy H Manson; Michelle A Lifton; Marcelo J Kuroda; Norman L Letvin; Gail P Mazzara; Dennis L Panicali
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors.

Authors:  Sampa Santra; Yue Sun; Jenny G Parvani; Valerie Philippon; Michael S Wyand; Kelledy Manson; Alicia Gomez-Yafal; Gail Mazzara; Dennis Panicali; Phillip D Markham; David C Montefiori; Norman L Letvin
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

4.  Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model.

Authors:  H L Kaufman; J B Rao; K R Irvine; V Bronte; S A Rosenberg; N P Restifo; K R Irivine
Journal:  J Immunother       Date:  1999-11       Impact factor: 4.456

5.  Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

Authors:  Junko Yokokawa; Claudia Palena; Philip Arlen; Raffit Hassan; Mitchell Ho; Ira Pastan; Jeffrey Schlom; Kwong Y Tsang
Journal:  Clin Cancer Res       Date:  2005-09-01       Impact factor: 12.531

6.  Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion.

Authors:  Daniel J Powell; Mark E Dudley; Katherine A Hogan; John R Wunderlich; Steven A Rosenberg
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

7.  Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

Authors:  K R Irvine; M R Parkhurst; E P Shulman; J P Tupesis; M Custer; C E Touloukian; P F Robbins; A G Yafal; P Greenhalgh; R P Sutmuller; R Offringa; S A Rosenberg; N P Restifo
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

8.  Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses.

Authors:  Sampa Santra; Dan H Barouch; Birgit Korioth-Schmitz; Carol I Lord; Georgia R Krivulka; Faye Yu; Margaret H Beddall; Darci A Gorgone; Michelle A Lifton; Ayako Miura; Valerie Philippon; Kelledy Manson; Phillip D Markham; John Parrish; Marcelo J Kuroda; Jörn E Schmitz; Rebecca S Gelman; John W Shiver; David C Montefiori; Dennis Panicali; Norman L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

9.  Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.

Authors:  Steven A Rosenberg; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Suzanne L Topalian; Richard M Sherry; Nicholas P Restifo; John R Wunderlich; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Linda Gritz; Dennis L Panicali; Donald E White
Journal:  Clin Cancer Res       Date:  2003-08-01       Impact factor: 12.531

10.  Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity.

Authors:  Hasan Zeytin; Eva Reali; David A Zaharoff; Connie J Rogers; Jeffrey Schlom; John W Greiner
Journal:  J Interferon Cytokine Res       Date:  2008-02       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.